Clinical Trials Directory

Trials / Completed

CompletedNCT07276516

Psychosocial Factors Related to Musculoskeletal Disorders in Academicians

The Investigation of the Effects of Academic Stress and Burnout on Musculoskeletal Disorders in Academicians

Status
Completed
Phase
Study type
Observational
Enrollment
99 (actual)
Sponsor
University of Yalova · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

the prevalence of occupational stress and burnout is very high among academicians. Previous studies examining MSDs in academicians have focused more on physical factors such as physical activity levels and ergonomics, while interest in psychosocial factors has been limited. To our knowledge, there is no study in the literature that evaluates both MSDs, work stress, and burnout in academicians. Therefore, our study aims to investigate the relationship between MSDs and academic stress, burnout, and work-life balance among academicians.

Detailed description

The study aims to investigate psychosocial factors such as academic stress and burnout, which are thought to influence musculoskeletal disorders among academics. As part of the research, data will be collected through questionnaires from volunteer academics at a selected university who have at least six months of teaching experience at the institution. The questionnaire will gather information on musculoskeletal pain, demographic characteristics, stress levels, burnout levels, and work-life balance. After entering the data into the SPSS software, statistical analysis will be conducted. Categorical variables will be presented as numbers (percentages), and numerical variables will be reported as means and standard deviations. To assess correlations, Spearman or Pearson correlation tests and regression analyses will be used. The Chi-square test will be used to compare categorical variables between male and female academics, while the independent samples t-test will be applied for numerical variables if normality is assumed; otherwise, the Mann-Whitney U test will be used. The Shapiro-Wilk test will be conducted to assess the normality of the data. A significance level of p\<0.005 will be considered statistically significant.

Conditions

Timeline

Start date
2025-01-02
Primary completion
2025-07-20
Completion
2025-07-20
First posted
2025-12-11
Last updated
2025-12-11

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07276516. Inclusion in this directory is not an endorsement.